Ontario, CA, Feb. 13, 2018 -- Kiwa Bio-Tech Products Group Corporation (OTCQB: KWBT) (“Kiwa Bio-Tech” or the “Company”), a manufacturer of eco-friendly biological fertilizers promoting safe agriculture practices, announced today that the Company has signed a five-year strategic cooperation agreement with the Yintai Bureau of Fruit Industry of Shaanxi Province (“Yintai Bureau”).
Under the agreement, Kiwa Bio-Tech will be granted for ¥100 million yuan (approximately US$15.81 million) by the Jingnong Public Welfare Foundation to restore polluted soil in Yintai District.
Under this cooperative venture, the parties intend to establish an eco-friendly fruit production base covering a total of 30,000 mu (approximately 2,000 hectares) in Yintai district, Shaanxi Province. In addition, pursuant to the agreement, a Kiwa Bio-Tech Tongchuan Retail Outlet Store in Yintai District will be opened to establish channels to introduce Yintai fruit products into high-end markets and the international market. Kiwa Bio-Tech believes that this will facilitate the strategic adaptation of the fruit industry in Yintai, which in turn will increase the income of the local farmers.
About Kiwa Bio-Tech Products Group Corporation
Leader in Harmless Agricultural Industry Chain
Kiwa Bio-Tech Products Group Corporation develops, manufactures, distributes, and markets innovative, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes.
Kiwa is dedicated to eco-agricultural development and environmental control by developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy the growing market demand. Kiwa’s development is creating a standardized and ecologically safe agricultural industry chain platform. The Company’s development effort is based in China, and has gradually expanded to the international market.
Kiwa uses new bio-technological skills at its core, with organic, ecologically sound, and “green” practices as its theme. The Company strives for customer satisfaction and continued development. Kiwa is dedicated to making safe food, further developing eco-agriculture and upholding a responsibility of contributing to China’s agricultural safety, food safety, and a healthy lifestyle. For more information on Kiwa and its products, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov.
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
CONTACT INFORMATION CONTACT: Kiwa Bio-Tech Products Group Corporation Molly Han Investor & Media Relations [email protected]


ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
FTC Questions Apple News Over Alleged Bias Against Conservative Media 



